A major problem in solid-phase peptide synthesis (SPPS) is aggregation and poor solvation leading to incomplete deprotection and/or coupling steps, resulting in low crude purity peptides. 1 This ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amide Technologies, a biotech that synthesizes challenging peptides, announced today that it has begun commercializing its novel peptide manufacturing platform. The ...
This >€500 million investment will feature multiple manufacturing lines capable of supporting small, medium, and large-scale peptide production with small- to large-scale Solid Phase Peptide Synthesis ...
Vapourtec's Peptide-Builder, a fully automated, high-throughput benchtop peptide synthesizer, has been designed to redefine solid-phase peptide synthesis (SPPS). Compact, efficient and intuitive, it ...
In synthetic research, all scientific decision-making ultimately rests on one thing: data. The ability to generate a product and acquire data about said product is paramount to making changes to ...
Aza-peptides, peptide analogues in which one or more α-carbon atoms are replaced by nitrogen atoms, represent a promising class of compounds in therapeutic development. This structural modification ...
Ottawa, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The global peptide therapeutics market size was valued at USD 51.81 billion in 2025 and is predicted to hit around USD 81.5 billion by 2034, rising at a 5.35% ...
Based on offerings, the market is segmented into products and services. By-products market is further divided into consumables and instruments. Among these consumables dominated the peptide synthesis ...
Expansion leverages proprietary chromatography expertise to overcome purification bottlenecks and secure domestic API manufacturing capacity SK pharmteco, a global contract development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback